Scale-up of a paediatric HIV disclosure intervention in Ghana using a stepped wedge cluster randomised trial design:

Nancy R Reynolds1, Veronika Shabanova2, Lorna Renner3

  • 1Johns Hopkins University, Baltimore, Maryland, USA nancy.reynolds@jhu.edu.

BMJ Open
|November 14, 2025
PubMed

Insights

The Sankofa 2 study is evaluating an intervention to help healthcare workers disclose HIV status to children and adolescents in Ghana. This larger trial builds on previous success to assess effectiveness, benefits, and costs for wider implementation.

Area of Science:

  • Public Health
  • Clinical Trials
  • HIV/AIDS Research

Background:

  • A significant need exists for interventions supporting healthcare workers and caregivers in disclosing HIV status to infected children and adolescents.
  • The Sankofa intervention was previously developed and tested successfully in Ghana.
  • The Sankofa 2 study aims to scale up and further evaluate this intervention.

Purpose of the Study:

  • To examine the effectiveness, health benefits, cost, and implementation of the Sankofa intervention in pediatric HIV care.
  • To provide insights for the scale-up and sustainability of the intervention.
  • To support healthcare workers and caregivers in the critical process of HIV status disclosure.

Main Methods:

  • A pragmatic, stepped-wedge cluster randomized trial design.
  • Conducting the study across 12 HIV pediatric clinics in Ghana.
  • Enrolling 700 caregiver-child dyads.

Main Results:

  • The study is ongoing, and results are pending.
  • Evaluation of effectiveness, health benefits, cost, and implementation are key objectives.
  • Insights for scale-up and sustainability are anticipated.

Conclusions:

  • The Sankofa 2 trial is expected to yield valuable data on the Sankofa intervention's impact.
  • Findings will inform strategies for improving pediatric HIV disclosure support.
  • The study aims to contribute to the long-term sustainability of effective HIV care practices.
Abstract